Nyxoah (NYXH) Research & Development (2025 - 2026)
Nyxoah's quarterly Research & Development came in at -$10307.2 in Q1 2026, down 9.01% year-on-year from -$11327.8 in Q1 2025, and down 9.01% quarter-over-quarter from -$9455.4 in Q1 2025.
Nyxoah has reported Research & Development for 2 years, with the latest figure at -$10307.2 in Q1 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn | 361.90 Mn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn | 249.00 Mn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn | 94.27 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn | 15.80 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn | 189.00 Mn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn | 44.30 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn | 98.66 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn | 139.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn | - |
| 10 | Nyxoah | 1,248.49 | 1,248.49 | 4.26 Mn | -10,307.24 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10,307.24 |
| Mar 31, 2025 | -9,455.39 |